碳离子再照射治疗碳离子放疗后复发胰腺癌的疗效与可行性
中位随访11个月,1年局部控制率、无进展生存率和总生存率分别为53.5%、24.5%和48.7%;仅1例(4.8%)出现3级急性毒性,无≥3级晚期毒性。辅助化疗与局部控制率改善显著相关(1年局部控制率80.0%对0.0%,P=0.0469)。
要点
- 再程碳离子放疗对复发性胰腺癌毒性可耐受,仅1例3级急性毒性。
- 1年局部控制率53.5%,无进展生存率24.5%,总生存率48.7%。
- 辅助化疗者1年局部控制率80.0%,未用者为0.0%(P=0.0469)。
核心结论
- 再次碳离子放疗可能是复发性胰腺癌毒性可耐受的合理选择。
- 辅助化疗似乎可改善再程碳离子放疗后的局部控制率。
研究设计与样本
- 初次碳离子放疗后失败部位为野内中心16例(76.2%)、边缘5例(23.8%)。
- 初次与再程碳离子放疗中位剂量均为52.8 Gy(RBE)。
主要发现
- 再照射后中位随访11个月,1年局部控制率53.5%、无进展生存率24.5%、总生存率48.7%。
- 仅1例(4.8%)出现3级急性毒性,无≥3级晚期毒性。
- 单因素分析显示辅助化疗者局部控制率显著优于未用者,1年局部控制率80.0%对0.0%(P=0.0469)。
关键数值与推荐
- 初次与再程碳离子放疗中位剂量均为52.8 Gy(RBE)。
- 辅助化疗者1年局部控制率80.0%,未用辅助化疗者0.0%(P=0.0469)。
临床怎么用
- 对初次碳离子放疗后局部区域复发的胰腺癌,可考虑再程碳离子放疗。
- 再程碳离子放疗后辅助化疗可能改善局部控制。
局限性
- 毒性数据来自病历记录。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Patients who receive carbon-ion radiotherapy (C-ion RT) for primary pancreatic cancer may experience locoregional recurrence; however, the treatment options for such patients are limited. We aimed to investigate the feasibility and efficacy of carbon-ion re-irradiation for patients with pancreatic cancer who experienced recurrence after initial C-ion RT. MATERIALS AND METHODS: Twenty-one patients with recurrent pancreatic cancer who underwent repeat C-ion RT between December 2010 and November 2016 at our institute were retrospectively evaluated. The sites of post-initial C-ion RT failure were in-field central in 16 patients (76.2%) and marginal in 5 (23.8%). The median doses of initial and repeat C-ion RT were both 52.8 Gy (relative biological effectiveness [RBE]). Thirteen patients (61.9%) received concurrent chemotherapy with re-irradiation, while 11 (52.4%) received adjuvant chemotherapy. RESULTS: The median follow-up period after re-irradiation was 11 months. The 1-year local control, progression-free survival, and overall survival rates were 53.5%, 24.5%, and 48.7%, respectively. Toxicity data was obtained from the patients' charts. Only 1 patient (4.8%) developed grade 3 acute toxicities and none developed grade ≥3 late toxicities. Univariate analysis indicated that patients who received adjuvant chemotherapy had significantly improved local control rates compared with those who did not; the 1-year local control rates were 80.0% and 0.0%, respectively (P = 0.0469). CONCLUSION: Repeating C-ion RT may be a reasonable option with tolerable toxicity for patients with recurrent pancreatic cancers. Adjuvant chemotherapy appears to improve the local control rate. This is the first study to examine re-irradiation using C-ion for recurrent pancreatic cancer after initial C-ion RT.
引用
- Hagiwara Y, Yamada S, Isozaki Y, et al. Efficacy and feasibility of re-irradiation using carbon ions for pancreatic cancer that recurs after carbon-ion radiotherapy. Clin Transl Radiat Oncol. 2020. PMID: 33294643. doi:10.1016/j.ctro.2020.10.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。